Search
for
Sort by
Research 151–180 of 1000+
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Current Treatments for Alopecia Areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Emerging drugs for alopecia areata: JAK inhibitors
- Novedades terapéuticas en tricología
- The role of oclacitinib in the management of ischaemic dermatopathy in four dogs
- Treatments options for alopecia
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Under Development JAK Inhibitors for Dermatologic Diseases
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Rethinking the classification of alopecia areata
- Alopecia in general medicine
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Alopecia areata – Current understanding and management
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Unraveling the secret life of the hair follicle: from fungi to innovative hair loss therapies
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Ruxolitinib found to cause eyelash growth: a case report
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Alopecia areata following COVID-19 vaccine: a systematic review